Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for Moderate to Severe Acute Respiratory Syndrome Caused by SARS-CoV-2

NCT04760821 is registered in ClinicalTrials.gov with Ministry of Health, Brazil as lead sponsor.

NCT NCT04760821
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04760821 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Acute Myocardial Injury by Trimetazidine in Patients Hospitalized for Moderate to Severe Acute Respiratory Syndrome Caused by SARS-CoV-2
Lead sponsor
Ministry of Health, Brazil
Phase
Phase 2
Overall status
Unknown status
Start date
December 10, 2020
Completion date
April 30, 2021
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory distress syndrome, covid19, myocardial injury